S&P 500   5,088.80
DOW   39,131.53
QQQ   436.78
A collection of the insights Warren Buffett offered in his annual letter Saturday
Here's Why Bitcoin Could Rise to $165,000 Starting Exactly On April 22, 2024. (Ad)
MILAN FASHION PHOTOS: Ferragamo, Dolce&Gabbana conceal and reveal, balance transparency with cover
Tax-free status of movie, music and games traded online is on table as WTO nations meet in Abu Dhabi
This is the #1 Stock to Buy for the AI Tidal Wave (Ad)
Consumers are increasingly pushing back against price increases — and winning
Delays in promised Western military aid to Ukraine are costing lives, the defense minister says
This is the #1 Stock to Buy for the AI Tidal Wave (Ad)
Corruption scandals cast a shadow over Portugal’s early general election and may favor populists
How this AP photographer captured a unique splash at the swimming worlds with an underwater camera
S&P 500   5,088.80
DOW   39,131.53
QQQ   436.78
A collection of the insights Warren Buffett offered in his annual letter Saturday
Here's Why Bitcoin Could Rise to $165,000 Starting Exactly On April 22, 2024. (Ad)
MILAN FASHION PHOTOS: Ferragamo, Dolce&Gabbana conceal and reveal, balance transparency with cover
Tax-free status of movie, music and games traded online is on table as WTO nations meet in Abu Dhabi
This is the #1 Stock to Buy for the AI Tidal Wave (Ad)
Consumers are increasingly pushing back against price increases — and winning
Delays in promised Western military aid to Ukraine are costing lives, the defense minister says
This is the #1 Stock to Buy for the AI Tidal Wave (Ad)
Corruption scandals cast a shadow over Portugal’s early general election and may favor populists
How this AP photographer captured a unique splash at the swimming worlds with an underwater camera
S&P 500   5,088.80
DOW   39,131.53
QQQ   436.78
A collection of the insights Warren Buffett offered in his annual letter Saturday
Here's Why Bitcoin Could Rise to $165,000 Starting Exactly On April 22, 2024. (Ad)
MILAN FASHION PHOTOS: Ferragamo, Dolce&Gabbana conceal and reveal, balance transparency with cover
Tax-free status of movie, music and games traded online is on table as WTO nations meet in Abu Dhabi
This is the #1 Stock to Buy for the AI Tidal Wave (Ad)
Consumers are increasingly pushing back against price increases — and winning
Delays in promised Western military aid to Ukraine are costing lives, the defense minister says
This is the #1 Stock to Buy for the AI Tidal Wave (Ad)
Corruption scandals cast a shadow over Portugal’s early general election and may favor populists
How this AP photographer captured a unique splash at the swimming worlds with an underwater camera
S&P 500   5,088.80
DOW   39,131.53
QQQ   436.78
A collection of the insights Warren Buffett offered in his annual letter Saturday
Here's Why Bitcoin Could Rise to $165,000 Starting Exactly On April 22, 2024. (Ad)
MILAN FASHION PHOTOS: Ferragamo, Dolce&Gabbana conceal and reveal, balance transparency with cover
Tax-free status of movie, music and games traded online is on table as WTO nations meet in Abu Dhabi
This is the #1 Stock to Buy for the AI Tidal Wave (Ad)
Consumers are increasingly pushing back against price increases — and winning
Delays in promised Western military aid to Ukraine are costing lives, the defense minister says
This is the #1 Stock to Buy for the AI Tidal Wave (Ad)
Corruption scandals cast a shadow over Portugal’s early general election and may favor populists
How this AP photographer captured a unique splash at the swimming worlds with an underwater camera

Zentalis Pharmaceuticals (ZNTL) Earnings Date, Estimates & Call Transcripts

$13.64
-0.31 (-2.22%)
(As of 02/23/2024 ET)
Skip Charts & View Estimated and Actual Earnings Data

ZNTL Earnings Estimates and Actuals by Quarter

The chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.

ZNTL Estimated and Actual Revenue by Quarter

The chart below shows up to four years of a company's revenue history. The dark blue line represents the company's actual revenue. The light blue line represents the company's estimated revenue based on the consensus of Wall Street analysts for each quarter.

Zentalis Pharmaceuticals Analyst EPS Estimates

QuarterNumber of EstimatesLow EstimateHigh EstimateAverage Estimate
Q1 20242($0.88)($0.83)($0.86)
Q2 20242($0.93)($0.88)($0.91)
Q3 20242($0.97)($0.94)($0.96)
Q4 20242($1.03)($0.84)($0.94)
FY 20248($3.81)($3.49)($3.65)

ZNTL Earnings Date and Information

Zentalis Pharmaceuticals has not formally confirmed its next earnings publication date, but the company's estimated earnings date is Wednesday, March 6th, 2024 based off prior year's report dates.

Zentalis Pharmaceuticals Earnings History by Quarter

DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueCall Transcript
3/6/2024
Estimated)
------- 
11/6/2023Q3 2023($0.92)($0.79)+$0.13($0.79)--  
8/9/2023Q2 2023($1.03)($1.85)($0.82)($1.85)--
5/10/2023Q1 2023($0.96)($1.07)($0.11)($1.07)--
3/1/2023Q4 2022($1.09)($0.92)+$0.17($0.92)--
11/9/2022Q3 2022($1.15)($0.96)+$0.19($0.96)--
8/9/2022Q2 2022($1.21)($1.34)($0.13)($1.34)--
5/5/2022Q1 2022($1.20)($1.31)($0.11)($1.31)--
2/24/2022Q4 2021($1.34)($1.11)+$0.23($1.11)--    
11/10/2021Q3 2021($1.31)($0.09)+$1.22($0.09)--
8/12/2021Q2 2021($1.13)($1.34)($0.21)($1.34)--
5/17/2021Q1 2021($0.97)($1.24)($0.27)($1.24)--
3/24/2021Q4 2020($0.95)($1.01)($0.06)($1.01)--












Zentalis Pharmaceuticals Earnings - Frequently Asked Questions

When is Zentalis Pharmaceuticals's earnings date?

Zentalis Pharmaceuticals has not confirmed its next earnings publication date, but the company's estimated earnings date is Wednesday, March 6th, 2024 based off last year's report dates. Learn more on ZNTL's earnings history.

How much profit does Zentalis Pharmaceuticals generate each year?

Zentalis Pharmaceuticals (NASDAQ:ZNTL) has a recorded net income of -$236.81 million. ZNTL has generated -$4.63 earnings per share over the last four quarters.

What is Zentalis Pharmaceuticals's EPS forecast for next year?

Zentalis Pharmaceuticals's earnings are expected to grow from ($4.49) per share to ($3.68) per share in the next year.


More Earnings Resources from MarketBeat

This page (NASDAQ:ZNTL) was last updated on 2/25/2024 by MarketBeat.com Staff